Clinical Trials in Atlanta

Showing 7321-7340 of 19,805 trials

Letrozole for Lymphangioleiomyomatosis

NCT01353209

The hypothesis in this study is that estrogen suppression by an aromatase inhibitor in postmenopausal women with lymphangioleiomyomatosis (LAM) will prevent or delay progression of lung disease and result in a decrease in the rate of decline in FEV1

Lymphangioleiomyomatosis

University of Cincinnati17 participantsStarted May 2011

Stanford, California, United States • Jacksonville, Florida, United States • Miami, Florida, United States +6 more locations

TERMINATEDPhase 1/2< 1 mile

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)

NCT04990388

The primary objective of the study is to evaluate the safety of UX053 in adults with Glycogen Storage Disease Type III (GSD III).

Glycogen Storage Disease Type III

Ultragenyx Pharmaceutical Inc9 participantsStarted Oct 2021

Orange, California, United States • Atlanta, Georgia, United States • Philadelphia, Pennsylvania, United States +3 more locations

Letrozole for Lymphangioleiomyomatosis

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)

Find Trials by Condition in Atlanta

Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant

Financial Incentives, Randomization With Stepped Treatment Trial

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Study Using Negative Pressure to Reduce Apnea

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease

BI 894999 First in Human Dose Finding Study in Advanced Malignancies

Expanded Access Program of Surufatinib

Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIIB107 in Healthy Adult Participants

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies